Roche Holding AG / Regeneron Pharmaceuticals, Inc.
2020 · Co-Development · Complete
Announcement Sentiment
77
Strongly positive
Roche and Regeneron announced a global collaboration to develop, manufacture and distribute REGN-COV2 (casirivimab + imdevimab) for COVID-19. Capacity to expand 3.5x; Regeneron led US distribution while Roche handled ex-US. Each company committed dedicated manufacturing capacity annually; jointly funded ongoing Phase 3 prevention and Phase 1 safety studies. Financial split not disclosed.